There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Medical Product Review Harmonization Act of 2017

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Federal Food, Drug, and Cosmetic Act to provide an alternative standard for substantial equivalence determinations for devices, and for other purposes.


Actions Overview (1)

Date
05/16/2017Introduced in House

All Actions (3)

Date
05/19/2017Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
05/16/2017Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
05/16/2017Introduced in House
Action By: House of Representatives

Cosponsors (1)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Bera, Ami [D-CA-7]* 05/16/2017

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce05/16/2017 Referred to
House Energy and Commerce Subcommittee on Health05/19/2017 Referred to

No related bill information was received for H.R.2474.


Subjects (4)


Latest Summary (1)

There is one summary for H.R.2474. View summaries

Shown Here:
Introduced in House (05/16/2017)

Medical Product Review Harmonization Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to establish an alternative standard for demonstrating a device's substantial equivalence to a medical device that has already been approved by the Food and Drug Administration.